Pathology labs still spend hours, and sometimes days, moving fragile tissue through reagent-intensive staining workflows that add cost, variability and waste. Virtual staining, an approach which uses AI models to transform label-free tissue images into counterparts that mimic chemical stains, aims to compress that process significantly while preserving scarce tissue and standardizing results across sites.…
Proscia launches ‘Aperture’ AI platform to accelerate clinical trial recruitment at point of diagnosis
Only 7.1% of U.S. adults with cancer enroll in treatment trials (JCO, 2024), a bottleneck that slows drug development and limits access to targeted therapies. Proscia, a Philadelphia-based digital pathology company, aims to address that dynamic with its new tool, Aperture, which uses AI to flag potential candidates right at the point of diagnosis by…